@article{5beda3268022470e88bfd323ceef254c,
title = "Toward a more complete understanding of who will benefit from prehospital transfusion",
keywords = "COMBAT, PAMPer, RePHILL, emergency medical service, mortality, outcome, prehospital transfusion, randomized trial, red blood cell, trauma",
author = "Yazer, \{Mark H.\} and Cap, \{Andrew P.\} and Elon Glassberg and Laura Green and Holcomb, \{John B.\} and Khan, \{Mansoor A.\} and Moore, \{Ernest E.\} and Neal, \{Matthew D.\} and Perkins, \{Gavin D.\} and Sperry, \{Jason L.\} and Patrick Thompson and Triulzi, \{Darrell J.\} and Spinella, \{Philip C.\}",
note = "Funding Information: Matthew D Neal serves on the scientific advisory board of Haima Therapeutics with equity stake. He has received research funding from the NIH, DoD, Haemonetics, and Instrumentation Laboratory. He has received honoraria from Haemonetics and Meredian. Gavin D Perkins declares funding from the NIHR Efficacy and Mechanism Evaluation Programme (14/152/14) and West Midlands Applied Research Collaboration. The other authors have no conflicts of interest to declare. The views expressed are those of the author(s) and not necessarily those of the UK NIHR, the UK Department of Health and Social Care, the US Department of the Army, the US Department of Defense, or the US government.",
year = "2022",
month = aug,
doi = "10.1111/trf.17012",
language = "English",
volume = "62",
pages = "1671--1679",
journal = "Transfusion",
issn = "0041-1132",
publisher = "John Wiley and Sons Inc",
number = "8",
}